FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

LH

LabcorpNYSE · Health Care Services · Health Care
Previous close
324.51
Change
+0.54 / +0.17%
FinDog View
Neutral
52-Week Range
244.52 – 341.80
P/E (TTM)
26.3
Forward P/E
16.7
Based on consensus earnings for the next 12 months
Market Cap
$26.3B
1M
+0.36%
S&P 500 −2.41% over same period
Volume / Avg Volume
562K / 740K
0.76× average

Price History

Closing price · USD1M6M1Y5Y
3003103203303402026-082026-082026-092026-092026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 27.31M6M1Y5Y
25262728292026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-30$3.7B4.99 / 4.92−2.01%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-30$3.5B4.25 / 4.21−0.37%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-17—— / —+0.76%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-28—— / —−4.45%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-24—— / —−1.02%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-29—— / —+0.25%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 28 of its 5-year rangeCheap
5-year range 21.9 – 45.6 · Median 29.0
Last 4 quarters: $702M in buybacks + $239M in dividends, 3.58% of market cap combined
P/E (TTM)
26.3
P/B
3.1
P/S
1.8
Dividend Yield
1.35%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.5% on average on the first trading day after, rising 2 times
Most recent −2.01%
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 6 · $3.3MNet selling $3.3M
  • 08-17ANDERSON KERRII BDirectorSell$0.95M3,000 shares · Avg price 318.02
  • 08-11Schechter Adam HPresident & CEOSell$1.5M4,669 shares · Avg price 320.37
  • 08-04Summy Amy B.EVP, Chief Marketing OfficerSell$0.28M924 shares · Avg price 306.74
  • 08-03Wilkinson Peter JSVP, Chief Accounting OfficerSell$0.44M1,420 shares · 2 trades · Avg price 309.23
  • 07-02Vaughn Bryan TEVP and President, DiagnosticsSell$0.07M234 shares · Avg price 286.19
  • 07-02Kyle Kathryn WEVP, Chief Legal OfficerSell$0.03M92 shares · Avg price 286.19
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q23.73+5.8%29.8%0.450.300.313.64
FY2026 Q13.54+5.8%28.7%0.380.280.073.35
FY2025 Q43.52+5.6%28.2%0.270.170.491.98
FY2025 Q33.56+8.6%28.8%0.400.260.283.12
FY2025 Q23.53+9.5%29.7%0.390.240.542.84
FY2025 Q13.35+5.3%28.3%0.330.21-0.112.52
FY2024 Q43.33+9.8%26.9%0.220.140.671.72
FY2024 Q33.28+7.4%27.6%0.250.170.162.00
FY2024 Q23.22+6.2%28.8%0.290.210.432.43
FY2024 Q13.18+4.6%28.2%0.320.23-0.162.69
FY2023 Q43.03+39.5%27.1%-0.12-0.170.41-1.85
FY2023 Q33.06+6.6%27.8%0.250.180.172.11

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
LHLabcorp$26.3B26.3+5.8%29.8%+0.36%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare